Coston, McIsaac & Partners
- SEC CIK
- 0001945037
- Latest filing
- Aug 12, 2026
LLY holding history
Eli Lilly & Co in every 13F filed by Coston, McIsaac & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LLY overviewAll 13F holders of LLYFull Q2 2026 holdings
- Shares (Q2 2026)
- 530
- Value
- $636.0K
- % of portfolio
- 0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 530 | $636.0K | 0.1% | +1+0.2% | Added | Holders |
| Q1 2026 | 529 | $486.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 529 | $568.0K | 0.1% | +1+0.2% | Added | Holders |
| Q3 2025 | 528 | $403.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 528 | $412.0K | 0.1% | +12+2.3% | Added | Holders |
| Q1 2025 | 516 | $426.0K | 0.1% | −3−0.6% | Reduced | Holders |
| Q4 2024 | 519 | $400.0K | 0.1% | +2+0.4% | Added | Holders |
| Q3 2024 | 517 | $458.0K | 0.1% | +1+0.2% | Added | Holders |
| Q2 2024 | 516 | $467.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 516 | $401.0K | 0.1% | +1+0.2% | Added | Holders |
| Q4 2023 | 515 | $300.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 515 | $276.0K | 0.1% | −23−4.3% | Reduced | Holders |
| Q2 2023 | 538 | $252.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 538 | $184.0K | 0.1% | +157+41.2% | Added | Holders |
| Q4 2022 | 381 | $139.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 381 | $123.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 381 | $124.0K | 0.1% | – | No prior filing | Holders |